Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma

BANG-BIN CHENYU-YUN SHAOZHONG-ZHE LINCHIH-HUNG HSUANN-LII CHENGCHIUN HSUPO-CHIN LIANGTIFFANY TING-FANG SHIH2021-12-152021-12-152021-07-262075-4418https://scholars.lib.ntu.edu.tw/handle/123456789/589958This study assessed dynamic contrast-enhanced (DCE)-MRI and intravoxel incoherent motion diffusion-weighted imaging (IVIM DWI) parameters to prospectively predict survival outcomes in participants with advanced hepatocellular carcinoma (HCC) who received lenalidomide, a dual antiangiogenic and immunomodulatory agent, as second-line therapy in a Phase II clinical trial.endiffusion MRI; hepatocellular carcinoma; lenalidomide; magnetic resonance angiography; survivalDynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinomajournal article10.3390/diagnostics11081340344412742-s2.0-85111710087https://scholars.lib.ntu.edu.tw/handle/123456789/577474